Tarsus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $32.57-$59.78 |
Market Cap | $2.4B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $295.5M |
Revenue Growth (YoY) | 151.5% |
Gross Profit (12 Mos) | $216.9M |
Diluted EPS | -$2.42 |
News
See moreYahoo Finance • 13 days ago
Interesting TARS Put And Call Options For November 21st
Yahoo Finance • last month
Tarsus to Participate in Upcoming Investor Conferences
Yahoo Finance • 2 months ago
This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine
Yahoo Finance • 2 months ago
Tarsus targets 95,000–100,000 bottles for Q3 2025 amid accelerated XDEMVY launch momentum
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 323 |
